These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9650218)

  • 1. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer].
    Ostwald E; Sabri O; Cremerius U; Jakse G; Büll U
    Nuklearmedizin; 1999; 38(7):302-5. PubMed ID: 10599071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
    Rudberg U; Udén R; Ahlbäck SO
    Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer].
    Otsuka N; Fukunaga M; Morita R; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A
    Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
    Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
    Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
    Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology].
    Feggi LM; Spanedda R; Scutellari PN; Prandini N; Gennari M; Orzincolo C; Scapoli GL; Bagni B
    Radiol Med; 1988 Oct; 76(4):311-5. PubMed ID: 3141987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
    Haddock G; Gray HW; McKillop JH; Bessent RG; Kirk D
    Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow regeneration after hormonal therapy in patients with bone metastases from prostate carcinoma.
    Berná L; Germá JR; Estorch M; Torres G; Blanco R; Carrió I
    J Nucl Med; 1991 Dec; 32(12):2295-8. PubMed ID: 1836021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of the superscan in prostatic bone scintigraphy.
    Constable AR; Cranage RW
    Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
    Bathmann J; Moser E
    Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
    Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
    Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic prostatic pulmonary nodules with normal bone image.
    Petras AF; Wollett FC
    J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-super bone scan caused by bone marrow involvement of prostate cancer.
    Seo Y; Shuke N; Yamamoto W; Usui K; Aburano T
    Ann Nucl Med; 1999 Oct; 13(5):351-4. PubMed ID: 10582806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
    Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U
    Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance.
    Berná L; Torres G; Carrió I; Estorch M; Germá JR; Alonso C
    Clin Nucl Med; 1994 Feb; 19(2):121-8. PubMed ID: 8187396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of planar scintigraphy and MRI in the screening of skeletal metastases].
    Silit E; Başekim CC; Mutlu H; Pekkafali Z; Kizilkaya E; Karsli AF
    Tani Girisim Radyol; 2003 Sep; 9(3):357-61. PubMed ID: 14661604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.
    Roudier MP; Vesselle H; True LD; Higano CS; Ott SM; King SH; Vessella RL
    Clin Exp Metastasis; 2003; 20(2):171-80. PubMed ID: 12705638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiologic diagnosis of bone metastases recurrence in patients with prostate cancer treated strontium-89].
    Barysheva EV; Selivanov SP; Riannel' IuE; Velichko SA; Usynin EA; Usov VIu
    Vestn Rentgenol Radiol; 1999; (5):32-6. PubMed ID: 12717923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoplastic bone metastases in prostatic carcinoma: magnetic resonance tomography and bone marrow scintigraphy].
    Venz S; Hosten N; Friedrichs R; Neumann K; Cordes M; Nagel R; Felix R
    Rofo; 1994 Jul; 161(1):64-9. PubMed ID: 8043767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.